UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Pharmacokinetics of meloxicam in animals and the relevance to humans

Drug metabolism and disposition, 1998-06, Vol.26 (6), p.576

1998

Link zum Volltext

Verfügbarkeit prüfen

Studies on antamanide. XIV. Mode of action

Hoppe-Seyler's Zeitschrift für Physiologische Chemie, 1972-08, Vol.353 (8), p.1337

1972

Link zum Volltext

Verfügbarkeit prüfen

Comparison of Atropine and Dexetimide in Treatment of Intoxications by Selected Organophosphates

Acta pharmacologica et toxicologica, 1982-03, Vol.50 (3), p.230-237

1982

Link zum Volltext

Verfügbarkeit prüfen

Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study

Neuro-oncology (Charlottesville, Va.), 2011-01, Vol.13 (1), p.132-142

2011

Link zum Volltext

Verfügbarkeit prüfen

Accumulation of small hyaluronan oligosaccharides in tumour interstitial fluid correlates with lymphatic invasion and lymph node metastasis

British journal of cancer, 2014-07, Vol.111 (3), p.559-567

2014

Link zum Volltext

Verfügbarkeit prüfen

Antisense Therapeutics for Tumor Treatment: The TGF-beta2 Inhibitor AP 12009 in Clinical Development Against Malignant Tumors

Pancreatic Cancer, 2008, Vol.177, p.137-150

2008

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of TRPV1 for the treatment of sensitive skin

Experimental dermatology, 2010-11, Vol.19 (11), p.980-986

2010

Link zum Volltext

Verfügbarkeit prüfen

Dermal Peptide Delivery Using Enhancer Molecules and Colloidal Carrier Systems – Part I: Carnosine

Skin pharmacology and physiology, 2012-01, Vol.25 (6), p.281-287

2012

Link zum Volltext

Verfügbarkeit prüfen

Modulation of Dihydroavenanthramide D release and skin penetration by 1,2-alkanediols

European journal of pharmaceutics and biopharmaceutics, 2008-09, Vol.70 (1), p.239-247

2008

Link zum Volltext

Verfügbarkeit prüfen

Inferring Semantic State Transitions During Telerobotic Manipulation

2018 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS), 2018, p.1-9

2018

Link zum Volltext
IEEE_Xplore

Surface relaxation and near-surface atomic displacements in the N/Cu(1 0 0) self-ordered system

Surface science, 2001-09, Vol.490 (3), p.336-350

2001

Link zum Volltext

Verfügbarkeit prüfen

Thoracic External Beam Radiotherapy in Patients with Airway Stent: A Retrospective Analysis of Outcome and Toxicity

International journal of radiation oncology, biology, physics, 2010, Vol.78 (3), p.S204-S204

2010

Link zum Volltext

Verfügbarkeit prüfen

Trabedersen (AP 12009) in the treatment of patients with advanced tumors: Completion of dose-escalation and first efficacy data

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.2611-2611

2010

Link zum Volltext

Verfügbarkeit prüfen

4-(1-Phenylethyl) 1,3-benzenediol: a new highly potent lightening agent

Journal of cosmetic science, 2006-03, Vol.57 (2), p.197-198

2006

Link zum Volltext

Verfügbarkeit prüfen

The reading frame BPLF1 of Epstein-Barr virus: a homologue of herpes simplex virus protein VP16

Virus genes, 2004-10, Vol.29 (2), p.267-277

2004

Link zum Volltext

Verfügbarkeit prüfen

Study of ion emission from a germanium crystal surface under impact of fast Pb ions in channeling conditions

Nuclear instruments & methods in physics research. Section B, Beam interactions with materials and atoms, 2009-03, Vol.267 (6), p.876-880

2009

Link zum Volltext

Verfügbarkeit prüfen

Thesinine-4′- O-β- d-glucoside the first glycosylated plant pyrrolizidine alkaloid from Borago officinalis

Phytochemistry (Oxford), 2002-06, Vol.60 (4), p.399-402

2002

Link zum Volltext

Verfügbarkeit prüfen

Phase I/II study with trabedersen (AP 12009) monotherapy for the treatment of patients with advanced pancreatic cancer, malignant melanoma, and colorectal carcinoma

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.2513-2513

2011

Link zum Volltext

Verfügbarkeit prüfen

Interim results of the phase I/II study of trabedersen (AP 12009) in patients with pancreatic carcinoma, malignant melanoma, or colorectal carcinoma

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.4619-4619

2009

Link zum Volltext

Verfügbarkeit prüfen

Preliminary results of a phase I/II study in patients with pancreatic carcinoma, malignant melanoma, or colorectal carcinoma using systemic i.v. administration of AP 12009

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.4621-4621

2008

Link zum Volltext

Verfügbarkeit prüfen

Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study

Neuro-oncology (Charlottesville, Va.), 2011-01, Vol.13 (1), p.132-142

2011

Link zum Volltext

Verfügbarkeit prüfen

Preliminary results of a phase I/II study in pancreatic carcinoma, malignant melanoma, and colorectal carcinoma with the TGF- β2 inhibitor AP 12009

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.4607-4607

2007

Link zum Volltext

Verfügbarkeit prüfen

Targeted tumor therapy with the TGF-beta2 antisense compound AP 12009 for the treatment of advanced solid tumors

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.14012-14012

2006

Link zum Volltext

Verfügbarkeit prüfen

Targeted down regulation of TGF-beta2 in pancreatic carcinoma: A phase I/II dose escalation study to evaluate the safety and tolerability of the antisense oligonucleotide AP 12009

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.4253-4253

2005

Link zum Volltext

Verfügbarkeit prüfen

4-(1-Phenylethyl)1,3-Benzenediol: A New, Highly Efficient Lightening Agent

International journal of cosmetic science, 2007-02, Vol.29 (1), p.65-66

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(37)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(20)
Humans
(12)
Life Sciences & Biomedicine
(11)
Physics
(11)
Physical Sciences
(9)
Animals
(7)
Physics, Atomic, Molecular & Chemical
(7)
Female
(6)
Biological And Medical Sciences
(5)
Male
(5)
Pharmacology & Pharmacy
(5)
Atomic Physics
(4)
Medical Sciences
(4)
Mice
(4)
Physics, Nuclear
(4)
Technology
(4)
Adult
(3)
Dermatology
(3)
Instruments & Instrumentation
(3)
Middle Aged
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics of meloxicam in animals and the relevance to humans

Studies on antamanide. XIV. Mode of action

Comparison of Atropine and Dexetimide in Treatment of Intoxications by Selected Organophosphates

Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study

Accumulation of small hyaluronan oligosaccharides in tumour interstitial fluid correlates with lymphatic invasion and lymph node metastasis

Antisense Therapeutics for Tumor Treatment: The TGF-beta2 Inhibitor AP 12009 in Clinical Development Against Malignant Tumors

Inhibition of TRPV1 for the treatment of sensitive skin

Dermal Peptide Delivery Using Enhancer Molecules and Colloidal Carrier Systems – Part I: Carnosine

Modulation of Dihydroavenanthramide D release and skin penetration by 1,2-alkanediols

Inferring Semantic State Transitions During Telerobotic Manipulation

Surface relaxation and near-surface atomic displacements in the N/Cu(1 0 0) self-ordered system

Thoracic External Beam Radiotherapy in Patients with Airway Stent: A Retrospective Analysis of Outcome and Toxicity

Trabedersen (AP 12009) in the treatment of patients with advanced tumors: Completion of dose-escalation and first efficacy data

4-(1-Phenylethyl) 1,3-benzenediol: a new highly potent lightening agent

The reading frame BPLF1 of Epstein-Barr virus: a homologue of herpes simplex virus protein VP16

Study of ion emission from a germanium crystal surface under impact of fast Pb ions in channeling conditions

Thesinine-4′- O-β- d-glucoside the first glycosylated plant pyrrolizidine alkaloid from Borago officinalis

Phase I/II study with trabedersen (AP 12009) monotherapy for the treatment of patients with advanced pancreatic cancer, malignant melanoma, and colorectal carcinoma

Interim results of the phase I/II study of trabedersen (AP 12009) in patients with pancreatic carcinoma, malignant melanoma, or colorectal carcinoma

Preliminary results of a phase I/II study in patients with pancreatic carcinoma, malignant melanoma, or colorectal carcinoma using systemic i.v. administration of AP 12009

Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study

Preliminary results of a phase I/II study in pancreatic carcinoma, malignant melanoma, and colorectal carcinoma with the TGF- β2 inhibitor AP 12009

Targeted tumor therapy with the TGF-beta2 antisense compound AP 12009 for the treatment of advanced solid tumors

Targeted down regulation of TGF-beta2 in pancreatic carcinoma: A phase I/II dose escalation study to evaluate the safety and tolerability of the antisense oligonucleotide AP 12009

4-(1-Phenylethyl)1,3-Benzenediol: A New, Highly Efficient Lightening Agent

Suchergebnisse filtern